Statement: dosage of ipatasertib and placebo for cohort 1 patients in the primary clinical trial is identical to that of cohort 2 patients
Primary_evidence: INTERVENTION 1:    Ipatasertib + Paclitaxel   Participants received ipatasertib orally daily on Days 1-21 of each 28-day cycle for 3 cycles and paclitaxel intravenous (IV) infusion every week (QW) for 3 cycles (12 total doses). INTERVENTION 2:    Placebo + Paclitaxel   Participants received placebo (matching to ipatasertib) orally daily on Days 1-21 of each 28-day cycle for 3 cycles and paclitaxel IV infusion QW for 3 cycles (12 total doses).